CLASS II Drug recall · Reported 27 Jan 2021 · FDA Enforcement Report

Refresh Relieva PF Preservative-Free Lubricant Eye Drops Sterile recalled

Allergan is recalling Refresh Relieva PF Preservative-Free Lubricant Eye Drops Sterile, distributed nationwide in the US. The recall was initiated on 30 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: T0392 Exp. Jul. 2022, T0843 Exp. Aug. 2022
NDC0023-6634
UPC300236634100
Quantity recalled100,634 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0233-2021
FDA event ID
87016
Recalling firm
Allergan, Madison, NJ
Manufacturer
Allergan, Inc.
Classification
Class II
Status
Terminated
Recall initiated
30 Dec 2020
FDA classified
19 Jan 2021
Reported
27 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Eye Drops

Timeline

30 Dec 2020Recall initiated by company
19 Jan 2021Classified by FDA+20 days
27 Jan 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Missing instructions for use insert

Product as listed by the FDA

Refresh Relieva PF Preservative-Free Lubricant Eye Drops 0.33 fl oz (10 mL) Sterile Distributed by: Allergan, an AbbVie company Madison, NJ 07940 UPC 3 00236 63410 0, NDC 0023-6634-10.

Where it was distributed

Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Missing instructions for use insert

Which lots are affected?

Lots: T0392 Exp. Jul. 2022, T0843 Exp. Aug. 2022

Where was it sold?

Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Allergan

All 29

Other Carboxymethylcellulose recalls

All 17